Spanish Pharmaceuticals & Biotech High Growth Potential Companies

Pharma Mar

Market Cap: €1.5b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Labiana Health

Market Cap: €28.6m

Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.

Oryzon Genomics

Market Cap: €241.3m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.

Almirall

Market Cap: €2.4b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Grifols

Market Cap: €7.3b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Faes Farma

Market Cap: €1.3b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.